检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张秀莲[1] 张伟华[1] 吴淑芬[1] 范星火[1] 李殿青[1]
机构地区:[1]山西医科大学第一医院血液科,太原030001
出 处:《临床血液学杂志》2006年第4期207-209,共3页Journal of Clinical Hematology
摘 要:目的:检测慢性再生障碍性贫血(CAA)患者骨髓单个核细胞(MNC)雄激素受体(AR)以及骨髓中T细胞亚群水平,探讨AR在CAA免疫病理机制中的作用。方法:①免疫细胞化学SP法检测CAA患者骨髓MNC内AR的表达水平;②流式细胞术检测CAA骨髓中T细胞亚群(CD3+CD4+细胞、CD3+CD8+细胞)的含量。结果:①CAA患者骨髓MNC中AR阳性水平[(35.18±8.78)个/200个MNC]显著低于对照组[(48.46±9.82)个/200个MNC];不同性别间AR的含量差异无统计学意义。②CAA患者骨髓中的CD3+CD8+细胞含量为(28.54±7.57)%,显著高于对照组。③CAA患者骨髓中的AR阳性水平与骨髓中的CD3+CD8+细胞呈负相关(r=-0.576,P<0.01);而与CD3+CD4+细胞含量未见明显的直线相关关系。结论:CAA患者骨髓AR的表达减少,从而使雄激素刺激造血的作用减弱。患者AR的表达与CD3+CD8+细胞含量呈明显负相关,表明AR的异常可能在一定程度上参与了CAA发病机制中的细胞免疫。Objeetive..To study the effect of androgen receptor (AR) on immune pathogenesis of chronic aplastic anemia(CAA). Method: ①lmmunocytochemistry was performed to evaluate the expression of AR in bone marrow mononuclear cells(MNCs) in 40 patients with chronic aplastic anemia. ②Flow cytometry was used to evaluate the contents of Tcell subpopulations(CD3^+ CD4^+ cells and CD3^+ CD8^+ cells) in bone marrow mononuclear cells. Result:The expression of AR in bone marrow MNCs of CAA patients was significantly lower than that of the con trol group; the contents of CD3^+ CD8^+ lymphocytes in CAA patients were significantly higher than that of the control group; In addition, the expression of AR in bone marrow had a negative relationship with CD3^+ CD8^+ lymphocytes in bone marrow. Condusion :. The lower expression of AR in CAA patients induced the weaker stimulating of androgen to hematopoiesis in bone marrow. The AR expression in patients had a negative relationship with the contents of CD3^+ CD8^+ lymphocytes, which suggested the abnormality of AR might have an effect on cellular immune in pathogenesis of chronic aplastic anemia.
分 类 号:R556.5[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15